Duration: (37) ?Subscribe5835 2025-02-28T23:39:59+00:00
Overdiagnosis | #activesurveillance #ProstateCancer #ASPI
(37)
Active Surveillance | #activesurveillance #ProstateCancer #ASPI #Gleason6
(56)
Segment 2: Risk Assessment in Prostate Cancer
(27:3)
Use of MRI Targeting Increases Overdiagnosis and Overtreatment
(11:33)
Active Surveillance From Biology to Bedside
(26:28)
Segment 3: Active Surveillance in Prostate Cancer
(19:11)
Active Surveillance in 2022 | Laurence Klotz, MD | PCRI
(57:33)
Active Surveillance with Dr. Laurence Klotz - ZERO Prostate Cancer Summit 2022
(49:7)
Active surveillance in localized prostate cancer
(4:12)
Dr. Loeb on the Results of Active Surveillance for Prostate Cancer
(1:28)
Active Surveillance vs. Watchful Waiting
(2:43)
When Is Active Surveillance Appropriate for Cancer Patients?
(1:36)
Active Surveillance: Risks and Controversies
(5:32)
Prostate Cancer: Active surveillance as a treatment option?
(58:16)
Anxiety, Mental Health \u0026 Active Surveillance | Experts Laurence Klotz, MD \u0026 Mark Moyad, MD Discuss
(4:38)
The Origins of Active Surveillance | Ask a Prostate Expert, Mark Scholz, MD
(2:17)
Active Surveillance of Prostate Cancer
(31:)
Identifying optimal candidates for active surveillance in prostate cancer
(2:11)
Active Surveillance for Prostate Cancer
(14:22)